ID IL1B_MOUSE Reviewed; 269 AA. AC P10749; Q2M4J6; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1989, sequence version 1. DT 27-MAR-2024, entry version 215. DE RecName: Full=Interleukin-1 beta; DE Short=IL-1 beta; DE Flags: Precursor; GN Name=Il1b; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3491144; RA Gray P.W., Glaister D., Chen E., Goeddel D.V., Pennica D.; RT "Two interleukin 1 genes in the mouse: cloning and expression of the cDNA RT for murine interleukin 1 beta."; RL J. Immunol. 137:3644-3648(1986). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3492706; DOI=10.1093/nar/14.24.9955; RA Telford J.L., Macchia G., Massone A., Carinci V., Palla E., Melli M.; RT "The murine interleukin 1 beta gene: structure and evolution."; RL Nucleic Acids Res. 14:9955-9963(1986). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=CAST/EiJ; TISSUE=Spleen; RA Farber C.R., Corva P.M., Medrano J.F.; RT "Characterization of quantitative trait loci influencing growth and RT adiposity using congenic mouse strains."; RL Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Czech II; TISSUE=Mammary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 118-139. RX PubMed=2967326; RA Huang J.J., Newton R.C., Rutledge S.J., Horuk R., Matthew J.B., RA Covington M., Lin Y.; RT "Characterization of murine IL-1 beta. Isolation, expression, and RT purification."; RL J. Immunol. 140:3838-3843(1988). RN [7] RP TISSUE SPECIFICITY, INDUCTION BY LPS, AND MISCELLANEOUS. RX PubMed=16407890; DOI=10.1038/nature04515; RA Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., RA Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., Dixit V.M.; RT "Cryopyrin activates the inflammasome in response to toxins and ATP."; RL Nature 440:228-232(2006). RN [8] RP SUBCELLULAR LOCATION, INDUCTION BY LPS, AND MISCELLANEOUS. RX PubMed=17284521; DOI=10.1242/jcs.03377; RA Brough D., Rothwell N.J.; RT "Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and RT precedes cell death."; RL J. Cell Sci. 120:772-781(2007). RN [9] RP SUBCELLULAR LOCATION, INDUCTION BY LPS, AND MISCELLANEOUS. RX PubMed=17641058; DOI=10.4049/jimmunol.179.3.1913; RA Qu Y., Franchi L., Nunez G., Dubyak G.R.; RT "Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent RT on inflammasome activation and correlated with exosome release in murine RT macrophages."; RL J. Immunol. 179:1913-1925(2007). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS). RX PubMed=1807351; DOI=10.1016/1047-8477(91)90021-n; RA van Oostrum J., Priestle J.P., Gruetter M.G., Schmitz A.; RT "The structure of murine interleukin-1 beta at 2.8-A resolution."; RL J. Struct. Biol. 107:189-195(1991). CC -!- FUNCTION: Potent pro-inflammatory cytokine. Initially discovered as the CC major endogenous pyrogen, induces prostaglandin synthesis, neutrophil CC influx and activation, T-cell activation and cytokine production, B- CC cell activation and antibody production, and fibroblast proliferation CC and collagen production. Promotes Th17 differentiation of T-cells. CC Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T- CC helper 1 (Th1) cells. Plays a role in angiogenesis by inducing VEGF CC production synergistically with TNF and IL6. Involved in transduction CC of inflammation downstream of pyroptosis: its mature form is CC specifically released in the extracellular milieu by passing through CC the gasdermin-D (GSDMD) pore. {ECO:0000250|UniProtKB:P01584}. CC -!- SUBUNIT: Monomer. Interacts with MEFV. Interacts with integrins CC ITGAV:ITGBV and ITGA5:ITGB1; integrin-binding is required for IL1B CC signaling. Interacts with cargo receptor TMED10; the interaction is CC direct and is required for the secretion of IL1B mature form (By CC similarity). Interacts with HSP90AB1; the interaction facilitates cargo CC translocation into the ERGIC (By similarity). Interacts with HSP90B1; CC the interaction facilitates cargo translocation into the ERGIC (By CC similarity). {ECO:0000250|UniProtKB:P01584}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17284521}. CC Secreted {ECO:0000269|PubMed:17284521, ECO:0000269|PubMed:17641058}. CC Lysosome {ECO:0000250|UniProtKB:P01584}. Secreted, extracellular CC exosome {ECO:0000269|PubMed:17641058}. Note=The precursor is cytosolic. CC In response to inflammasome-activating signals, such as ATP for NLRP3 CC inflammasome or bacterial flagellin for NLRC4 inflammasome, cleaved and CC secreted. Mature form is secreted and released in the extracellular CC milieu by passing through the gasdermin-D (GSDMD) pore. In contrast, CC the precursor form is not released, due to the presence of an acidic CC region that is proteolytically removed by CASP1 during maturation. The CC secretion is dependent on protein unfolding and facilitated by the CC cargo receptor TMED10. {ECO:0000250|UniProtKB:P01584}. CC -!- TISSUE SPECIFICITY: Expressed in activated macrophages (at protein CC level). {ECO:0000269|PubMed:16407890, ECO:0000269|PubMed:17284521, CC ECO:0000269|PubMed:17641058}. CC -!- INDUCTION: By LPS. {ECO:0000269|PubMed:16407890, CC ECO:0000269|PubMed:17284521, ECO:0000269|PubMed:17641058}. CC -!- MISCELLANEOUS: IL1B production occurs in 2 steps, each being controlled CC by different stimuli. First, inflammatory signals, such as LPS, CC stimulate the synthesis and promote the accumulation of cytosolic CC stores of pro-IL1B (priming). Then additional signals are required for CC inflammasome assembly, leading to CASP1 activation, pro-IL1B processing CC and eventually secretion of the active cytokine. IL1B processing and CC secretion are temporarily associated. {ECO:0000269|PubMed:17284521, CC ECO:0000269|PubMed:17641058}. CC -!- SIMILARITY: Belongs to the IL-1 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M15131; AAA39276.1; -; mRNA. DR EMBL; X04964; CAA28637.1; -; Genomic_DNA. DR EMBL; AY902319; AAX90604.1; -; Genomic_DNA. DR EMBL; CH466519; EDL28238.1; -; Genomic_DNA. DR EMBL; BC011437; AAH11437.1; -; mRNA. DR CCDS; CCDS16726.1; -. DR PIR; I55969; I55969. DR RefSeq; NP_032387.1; NM_008361.4. DR PDB; 2MIB; X-ray; 2.84 A; A=118-269. DR PDB; 8I1B; X-ray; 2.40 A; A=118-269. DR PDBsum; 2MIB; -. DR PDBsum; 8I1B; -. DR AlphaFoldDB; P10749; -. DR SMR; P10749; -. DR BioGRID; 200624; 8. DR IntAct; P10749; 1. DR STRING; 10090.ENSMUSP00000028881; -. DR BindingDB; P10749; -. DR ChEMBL; CHEMBL5069361; -. DR iPTMnet; P10749; -. DR PhosphoSitePlus; P10749; -. DR PaxDb; 10090-ENSMUSP00000028881; -. DR ProteomicsDB; 266968; -. DR TopDownProteomics; P10749; -. DR ABCD; P10749; 1 sequenced antibody. DR Antibodypedia; 771; 2657 antibodies from 51 providers. DR DNASU; 16176; -. DR Ensembl; ENSMUST00000028881.14; ENSMUSP00000028881.8; ENSMUSG00000027398.14. DR GeneID; 16176; -. DR KEGG; mmu:16176; -. DR UCSC; uc008mht.1; mouse. DR AGR; MGI:96543; -. DR CTD; 3553; -. DR MGI; MGI:96543; Il1b. DR VEuPathDB; HostDB:ENSMUSG00000027398; -. DR eggNOG; ENOG502S3E9; Eukaryota. DR GeneTree; ENSGT00950000182943; -. DR HOGENOM; CLU_083639_0_0_1; -. DR InParanoid; P10749; -. DR OMA; QKCLVMS; -. DR OrthoDB; 4264279at2759; -. DR PhylomeDB; P10749; -. DR TreeFam; TF300203; -. DR Reactome; R-MMU-448706; Interleukin-1 processing. DR Reactome; R-MMU-5620971; Pyroptosis. DR Reactome; R-MMU-5660668; CLEC7A/inflammasome pathway. DR Reactome; R-MMU-9020702; Interleukin-1 signaling. DR BioGRID-ORCS; 16176; 1 hit in 79 CRISPR screens. DR ChiTaRS; Il1b; mouse. DR EvolutionaryTrace; P10749; -. DR PRO; PR:P10749; -. DR Proteomes; UP000000589; Chromosome 2. DR RNAct; P10749; Protein. DR Bgee; ENSMUSG00000027398; Expressed in granulocyte and 65 other cell types or tissues. DR GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell. DR GO; GO:0005576; C:extracellular region; ISO:MGI. DR GO; GO:0005615; C:extracellular space; IDA:CAFA. DR GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell. DR GO; GO:0030141; C:secretory granule; IDA:MGI. DR GO; GO:0031982; C:vesicle; IDA:MGI. DR GO; GO:0005125; F:cytokine activity; IDA:MGI. DR GO; GO:0005178; F:integrin binding; ISS:UniProtKB. DR GO; GO:0005149; F:interleukin-1 receptor binding; IEA:InterPro. DR GO; GO:0019904; F:protein domain specific binding; ISO:MGI. DR GO; GO:0048018; F:receptor ligand activity; IDA:MGI. DR GO; GO:0048143; P:astrocyte activation; IDA:MGI. DR GO; GO:0097398; P:cellular response to interleukin-17; IDA:MGI. DR GO; GO:0071222; P:cellular response to lipopolysaccharide; IBA:GO_Central. DR GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl. DR GO; GO:0071310; P:cellular response to organic substance; ISO:MGI. DR GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:MGI. DR GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:MGI. DR GO; GO:0050830; P:defense response to Gram-positive bacterium; ISO:MGI. DR GO; GO:0035234; P:ectopic germ cell programmed cell death; IGI:MGI. DR GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IMP:MGI. DR GO; GO:0001660; P:fever generation; IEA:UniProtKB-KW. DR GO; GO:0030213; P:hyaluronan biosynthetic process; ISO:MGI. DR GO; GO:0006955; P:immune response; IEA:InterPro. DR GO; GO:0006954; P:inflammatory response; ISO:MGI. DR GO; GO:0070498; P:interleukin-1-mediated signaling pathway; ISO:MGI. DR GO; GO:0007254; P:JNK cascade; IDA:MGI. DR GO; GO:0050900; P:leukocyte migration; IDA:MGI. DR GO; GO:0007613; P:memory; ISO:MGI. DR GO; GO:0070487; P:monocyte aggregation; ISO:MGI. DR GO; GO:0070164; P:negative regulation of adiponectin secretion; IDA:BHF-UCL. DR GO; GO:2000173; P:negative regulation of branching morphogenesis of a nerve; ISO:MGI. DR GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:MGI. DR GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:MGI. DR GO; GO:1903597; P:negative regulation of gap junction assembly; ISO:MGI. DR GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI. DR GO; GO:0010829; P:negative regulation of glucose transmembrane transport; IDA:BHF-UCL. DR GO; GO:0014050; P:negative regulation of glutamate secretion; ISO:MGI. DR GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0050995; P:negative regulation of lipid catabolic process; ISO:MGI. DR GO; GO:0045833; P:negative regulation of lipid metabolic process; IDA:BHF-UCL. DR GO; GO:0043407; P:negative regulation of MAP kinase activity; IDA:BHF-UCL. DR GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; ISO:MGI. DR GO; GO:0050768; P:negative regulation of neurogenesis; ISO:MGI. DR GO; GO:0045665; P:negative regulation of neuron differentiation; ISO:MGI. DR GO; GO:0050805; P:negative regulation of synaptic transmission; IMP:ARUK-UCL. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:MGI. DR GO; GO:0030593; P:neutrophil chemotaxis; IDA:MGI. DR GO; GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL. DR GO; GO:0043065; P:positive regulation of apoptotic process; ISO:MGI. DR GO; GO:0048711; P:positive regulation of astrocyte differentiation; ISO:MGI. DR GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; IDA:MGI. DR GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW. DR GO; GO:0030335; P:positive regulation of cell migration; ISO:MGI. DR GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:MGI. DR GO; GO:0032722; P:positive regulation of chemokine production; IDA:MGI. DR GO; GO:0045917; P:positive regulation of complement activation; ISO:MGI. DR GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:MGI. DR GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:MGI. DR GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:MGI. DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:MGI. DR GO; GO:0031622; P:positive regulation of fever generation; IDA:BHF-UCL. DR GO; GO:0010628; P:positive regulation of gene expression; IDA:MGI. DR GO; GO:0045687; P:positive regulation of glial cell differentiation; ISO:MGI. DR GO; GO:0060252; P:positive regulation of glial cell proliferation; ISO:MGI. DR GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISO:MGI. DR GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISO:MGI. DR GO; GO:0033092; P:positive regulation of immature T cell proliferation in thymus; ISO:MGI. DR GO; GO:0050729; P:positive regulation of inflammatory response; ISO:MGI. DR GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:MGI. DR GO; GO:0032755; P:positive regulation of interleukin-6 production; IDA:UniProtKB. DR GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:MGI. DR GO; GO:0046330; P:positive regulation of JNK cascade; IDA:MGI. DR GO; GO:0050996; P:positive regulation of lipid catabolic process; IDA:BHF-UCL. DR GO; GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; ISO:MGI. DR GO; GO:0045840; P:positive regulation of mitotic nuclear division; ISO:MGI. DR GO; GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; ISO:MGI. DR GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:MGI. DR GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISO:MGI. DR GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISO:MGI. DR GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:MGI. DR GO; GO:1900745; P:positive regulation of p38MAPK cascade; IGI:ARUK-UCL. DR GO; GO:0031394; P:positive regulation of prostaglandin biosynthetic process; ISO:MGI. DR GO; GO:0032308; P:positive regulation of prostaglandin secretion; IDA:BHF-UCL. DR GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:MGI. DR GO; GO:1902680; P:positive regulation of RNA biosynthetic process; ISO:MGI. DR GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; ISO:MGI. DR GO; GO:0042102; P:positive regulation of T cell proliferation; ISO:MGI. DR GO; GO:2000556; P:positive regulation of T-helper 1 cell cytokine production; ISS:UniProtKB. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI. DR GO; GO:0032729; P:positive regulation of type II interferon production; ISS:UniProtKB. DR GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; IMP:BHF-UCL. DR GO; GO:0043122; P:regulation of canonical NF-kappaB signal transduction; ISO:MGI. DR GO; GO:0050691; P:regulation of defense response to virus by host; IDA:CAFA. DR GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISO:MGI. DR GO; GO:1903140; P:regulation of establishment of endothelial barrier; ISO:MGI. DR GO; GO:0050796; P:regulation of insulin secretion; ISO:MGI. DR GO; GO:0050767; P:regulation of neurogenesis; ISO:MGI. DR GO; GO:0050999; P:regulation of nitric-oxide synthase activity; IDA:UniProtKB. DR GO; GO:0033198; P:response to ATP; IDA:MGI. DR GO; GO:0009743; P:response to carbohydrate; IDA:MGI. DR GO; GO:0070555; P:response to interleukin-1; ISO:MGI. DR GO; GO:0032496; P:response to lipopolysaccharide; IDA:MGI. DR GO; GO:0030730; P:sequestering of triglyceride; ISO:MGI. DR GO; GO:0035176; P:social behavior; ISO:MGI. DR GO; GO:0010573; P:vascular endothelial growth factor production; ISS:UniProtKB. DR CDD; cd00100; IL1; 1. DR Gene3D; 2.80.10.50; -; 1. DR InterPro; IPR020877; IL-1_CS. DR InterPro; IPR000975; IL-1_fam. DR InterPro; IPR003502; IL-1_propep. DR InterPro; IPR008996; IL1/FGF. DR PANTHER; PTHR10078:SF30; INTERLEUKIN-1 BETA; 1. DR PANTHER; PTHR10078; INTERLEUKIN-1 FAMILY MEMBER; 1. DR Pfam; PF00340; IL1; 1. DR Pfam; PF02394; IL1_propep; 1. DR PRINTS; PR00262; IL1HBGF. DR PRINTS; PR00264; INTERLEUKIN1. DR PRINTS; PR01359; INTRLEUKIN1B. DR PRINTS; PR01357; INTRLEUKN1AB. DR SMART; SM00125; IL1; 1. DR SUPFAM; SSF50353; Cytokine; 1. DR PROSITE; PS00253; INTERLEUKIN_1; 1. DR Genevisible; P10749; MM. PE 1: Evidence at protein level; KW 3D-structure; Cytokine; Cytoplasm; Direct protein sequencing; KW Inflammatory response; Lysosome; Mitogen; Pyrogen; Reference proteome; KW Secreted. FT PROPEP 1..117 FT /evidence="ECO:0000269|PubMed:2967326" FT /id="PRO_0000015311" FT CHAIN 118..269 FT /note="Interleukin-1 beta" FT /id="PRO_0000015312" FT SITE 172 FT /note="Important for interaction with integrin" FT /evidence="ECO:0000250|UniProtKB:P01584" FT SITE 180 FT /note="Important for interaction with integrin" FT /evidence="ECO:0000250|UniProtKB:P01584" FT SITE 182 FT /note="Important for interaction with integrin" FT /evidence="ECO:0000250|UniProtKB:P01584" FT SITE 191 FT /note="Important for interaction with integrin" FT /evidence="ECO:0000250|UniProtKB:P01584" FT SITE 205 FT /note="Important for interaction with integrin" FT /evidence="ECO:0000250|UniProtKB:P01584" FT STRAND 123..129 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 134..138 FT /evidence="ECO:0007829|PDB:8I1B" FT TURN 139..141 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 142..146 FT /evidence="ECO:0007829|PDB:8I1B" FT HELIX 150..153 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 159..163 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 170..179 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 182..191 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 194..201 FT /evidence="ECO:0007829|PDB:8I1B" FT TURN 204..206 FT /evidence="ECO:0007829|PDB:8I1B" FT HELIX 214..216 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 217..223 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 226..234 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 238..241 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 243..248 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 250..252 FT /evidence="ECO:0007829|PDB:8I1B" FT STRAND 256..259 FT /evidence="ECO:0007829|PDB:2MIB" FT STRAND 262..266 FT /evidence="ECO:0007829|PDB:8I1B" SQ SEQUENCE 269 AA; 30931 MW; 734FA17B02ED87EE CRC64; MATVPELNCE MPPFDSDEND LFFEVDGPQK MKGCFQTFDL GCPDESIQLQ ISQQHINKSF RQAVSLIVAV EKLWQLPVSF PWTFQDEDMS TFFSFIFEEE PILCDSWDDD DNLLVCDVPI RQLHYRLRDE QQKSLVLSDP YELKALHLNG QNINQQVIFS MSFVQGEPSN DKIPVALGLK GKNLYLSCVM KDGTPTLQLE SVDPKQYPKK KMEKRFVFNK IEVKSKVEFE SAEFPNWYIS TSQAEHKPVF LGNNSGQDII DFTMESVSS //